Editorial: Targeting innate and adaptive immunity for improvement of cardiovascular disease.
作者信息
Janssen Henrike, Wagner Nana Maria, Napp L Christian, Larmann Jan
机构信息
Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.
Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.
出版信息
Front Physiol. 2022 Aug 11;13:952837. doi: 10.3389/fphys.2022.952837. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Targeting innate and adaptive immunity for improvement of cardiovascular disease.社论：针对先天性和适应性免疫以改善心血管疾病
Front Physiol. 2022 Aug 11;13:952837. doi: 10.3389/fphys.2022.952837. eCollection 2022.
2
Innate and adaptive immunity in atherosclerosis.动脉粥样硬化中的固有免疫和适应性免疫
Semin Immunopathol. 2009 Jun;31(1):5-22. doi: 10.1007/s00281-009-0153-8. Epub 2009 May 16.
3
Trained Immunity: An Underlying Driver of Inflammatory Atherosclerosis.训练免疫：炎症性动脉粥样硬化的潜在驱动因素。
Front Immunol. 2020 Feb 21;11:284. doi: 10.3389/fimmu.2020.00284. eCollection 2020.
4
Adaptive immunity-driven inflammation and cardiovascular disease.适应性免疫驱动的炎症与心血管疾病。
Am J Physiol Heart Circ Physiol. 2019 Dec 1;317(6):H1254-H1257. doi: 10.1152/ajpheart.00642.2019. Epub 2019 Nov 8.
5
Innate and adaptive immunity in cardiovascular calcification.先天性和适应性免疫在心血管钙化中的作用。
Atherosclerosis. 2020 Aug;306:59-67. doi: 10.1016/j.atherosclerosis.2020.02.016. Epub 2020 Feb 28.
6
Immune-mediated mechanisms of atherosclerosis and implications for the clinic.免疫介导的动脉粥样硬化机制及其对临床的影响。
Expert Rev Clin Immunol. 2016 Nov;12(11):1217-1237. doi: 10.1080/1744666X.2016.1195686. Epub 2016 Jun 20.
7
Innate and adaptive immunity in the pathogenesis of atherosclerosis.动脉粥样硬化发病机制中的固有免疫和适应性免疫。
Circ Res. 2002 Aug 23;91(4):281-91. doi: 10.1161/01.res.0000029784.15893.10.
8
The association of innate and adaptive immunity, subclinical atherosclerosis, and cardiovascular disease in the Rotterdam Study: A prospective cohort study.先天免疫和适应性免疫、亚临床动脉粥样硬化与心血管疾病在鹿特丹研究中的关联：一项前瞻性队列研究。
PLoS Med. 2020 May 7;17(5):e1003115. doi: 10.1371/journal.pmed.1003115. eCollection 2020 May.
9
Trained Immunity: Linking Obesity and Cardiovascular Disease across the Life-Course?训练免疫：在整个生命过程中连接肥胖与心血管疾病？
Trends Endocrinol Metab. 2020 May;31(5):378-389. doi: 10.1016/j.tem.2020.01.008. Epub 2020 Feb 8.
10
Innate and adaptive inflammation as a therapeutic target in vascular disease: the emerging role of statins.先天和适应性炎症作为血管疾病的治疗靶点：他汀类药物的新作用。
J Am Coll Cardiol. 2014 Jun 17;63(23):2491-2502. doi: 10.1016/j.jacc.2014.01.054. Epub 2014 Mar 5.
本文引用的文献
1
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?靶向动脉粥样硬化炎症和免疫的治疗策略：如何进行？
Nat Rev Cardiol. 2022 Aug;19(8):522-542. doi: 10.1038/s41569-021-00668-4. Epub 2022 Jan 31.
2
Lessons Learned From 10 Years of Preschool Intervention for Health Promotion: JACC State-of-the-Art Review.从 10 年促进健康的学前干预中吸取的教训：JACC 最新技术评论。
J Am Coll Cardiol. 2022 Jan 25;79(3):283-298. doi: 10.1016/j.jacc.2021.10.046.
3
Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018.美国成年人糖尿病治疗和控制的趋势，1999-2018 年。
N Engl J Med. 2021 Jun 10;384(23):2219-2228. doi: 10.1056/NEJMsa2032271.
4
Colchicine in Patients with Chronic Coronary Disease.秋水仙碱治疗慢性冠心病
N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31.
5
Sequential Surgical Procedures in Vascular Surgery Patients Are Associated With Perioperative Adverse Cardiac Events.血管外科患者的序贯手术与围手术期不良心脏事件相关。
Front Cardiovasc Med. 2020 Feb 18;7:13. doi: 10.3389/fcvm.2020.00013. eCollection 2020.
6
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.心梗后小剂量秋水仙碱的疗效和安全性。
N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388. Epub 2019 Nov 16.
7
Primary prevention of ischaemic heart disease: populations, individuals, and health professionals.缺血性心脏病的一级预防：人群、个体和卫生专业人员。
Lancet. 2019 Aug 24;394(10199):685-696. doi: 10.1016/S0140-6736(19)31893-8.
8
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17.
9
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
10
Acute perioperative-stress-induced increase of atherosclerotic plaque volume and vulnerability to rupture in apolipoprotein-E-deficient mice is amenable to statin treatment and IL-6 inhibition.急性围手术期应激诱导载脂蛋白E缺乏小鼠动脉粥样硬化斑块体积增加及破裂易感性增加，他汀类药物治疗和白细胞介素-6抑制对此有效。
Dis Model Mech. 2015 Sep;8(9):1071-80. doi: 10.1242/dmm.018713. Epub 2015 Jun 18.
Zotero 插件